Distribution of immunoreactivity for Cystatin B and Cathepsin S in the brain of Progressive myoclonus epilepsy (EPM1) patients

被引：0
|
作者：
D'Amato, E
Haltia, M
Rinne, A
de la Chapelle, A
Lehesjoki, AE
机构：
[1] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland
[2] Folkhalsan Inst Genet, FIN-00280 Helsinki, Finland
[3] Univ Helsinki, Dept Pathol, Helsinki, Finland
[4] Univ Tromso, Dept Med Biol, N-9037 Tromso, Norway
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 1998年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P4211
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [31] Early Microglial Activation Precedes Neuronal Loss in the Brain of the Cstb-/- Mouse Model of Progressive Myoclonus Epilepsy, EPM1
    Tegelberg, Saara
    Kopra, Outi
    Joensuu, Tarja
    Cooper, Jonathan D.
    Lehesjoki, Anna-Elina
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (01): : 40 - 53
  • [32] Early activation of microglia plays a central role in the disease pathogenesis of progressive myoclonus epilepsy, EPM1
    Korber, I.
    Joensuu, T.
    Katayama, S.
    Hakala, P.
    Einarsdottir, E.
    Kere, J.
    Lehesjoki, A. -E.
    GLIA, 2015, 63 : E169 - E169
  • [33] Microglia-mediated synaptic pruning in the Cstb-/- mouse model for progressive myoclonus epilepsy, EPM1
    Tegelberg, S.
    Hakala, P.
    Joensuu, T.
    Lehesjoki, A-E.
    GLIA, 2017, 65 : E313 - E313
  • [34] Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1)
    M K Houseweart
    A Vilaythong
    X-M Yin
    B Turk
    J L Noebels
    R M Myers
    Cell Death & Differentiation, 2003, 10 : 1329 - 1335
  • [35] Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1)
    Houseweart, MK
    Vilaythong, A
    Yin, XM
    Turk, B
    Noebels, JL
    Myers, RM
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (12): : 1329 - 1335
  • [36] Sleep architecture, interictal epieptiform discharges and sleep co-morbidities in patients with progressive myoclonus epilepsy type 1 (EPM1)
    Hypponen, J.
    Saisanen, L.
    Kalviainen, R.
    Mervaala, E.
    EPILEPSIA, 2022, 63 : 29 - 29
  • [37] Microglia mediated synaptic pruning is altered in the Cstb-/- mouse model for progressive myoclonus epilepsy, EPM1
    Tegelberg, S.
    Kuosa, E.
    Kallo, H.
    Hakala, P.
    Joensuu, T.
    Lehesjoki, A. -E.
    GLIA, 2019, 67 : E350 - E351
  • [38] Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1
    Virtaneva, K
    DAmato, E
    Miao, IM
    Koskiniemi, M
    Norio, R
    Avanzini, G
    Franceschetti, S
    Michelucci, R
    Tassinari, CA
    Omer, S
    Pennacchio, LA
    Myers, RM
    DieguezLucena, JL
    Krahe, R
    delaChapelle, A
    Lehesjoki, AE
    NATURE GENETICS, 1997, 15 (04) : 393 - 396
  • [39] A NEW CDNA FROM THE BALTIC PROGRESSIVE MYOCLONUS EPILEPSY (EPM1) REGION ON 21Q22.3
    BESPALOVA, IN
    ADKINS, S
    BURMEISTER, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 794 - 794
  • [40] CLONING OF THE PROGRESSIVE MYOCLONUS EPILEPSY TYPE-1 (EPM1) CANDIDATE REGION IN 21Q22.3
    LAFRENIERE, RG
    ROMMENS, J
    FON, T
    KIBAR, Z
    DUBE, MP
    DEJONG, P
    ROULEAU, GA
    EPILEPSIA, 1995, 36 : S5 - S6
12345